Surgery – Means for introducing or removing material from body for... – Infrared – visible light – ultraviolet – x-ray or electrical...
Patent
1992-10-14
1995-06-06
Cohen, Lee S.
Surgery
Means for introducing or removing material from body for...
Infrared, visible light, ultraviolet, x-ray or electrical...
A61B 1700
Patent
active
054218160
ABSTRACT:
Ultrasonic energy is used to release a stored drug and forcibly move the drug through the skin of an organism into the blood stream. A housing (81) includes a cavity (67) defined by an assembly of ultrasonic transducers (65) and separated from the skin by a polymeric membrane (69) that stores the drug to be delivered. The ultrasonic transducer assembly includes a flat, circular ultrasonic transducer (85) that defines the top of a truncated cone and a plurality of transducer segments (87a, 87b, 87c, 87d . . . ) that define the walls of the cone. The resonant frequency of the planar transducer is lower than the resonant frequency of the transducer segments. The planar, flat, circular transducer generates fixed frequency (5 KHz-1 MHz range) ultrasonic stimuli impulses for a predetermined period of time (10-20 seconds). Between the stimuli pulse periods, the transducer segments receive variable frequency ultrasonic pumping pulses. Preferably, the variable frequency ultrasonic pumping pulses lie in the 50 MHz-300 MHz range. The variable frequency ultrasonic pumping pulses are applied to opposed transducer segments. The transducer segments create beams that impinge on the skin at an oblique angle and create a pulsating wave. Further, the variable frequency ultrasonic pumping pulses are applied to opposing transducer segments in a rotating manner to create pulsating waves in the skin in a variety of directions. The stimuli pulses cause the planar transducer to produce an ultrasonic wave that excites the local nerves in the way that trauma (heat, force) excites the local nerves. The nerve excitation opens the epidermal/dermal junction membrane and the capillary endothelial cell joints. The variable frequency ultrasonic pumping pulses cause the transducer segments to produce ultrasonic waves in both the polymeric membrane and the skin. The ultrasonic waves pump the drug first through the polymeric membrane and then through, skin openings into the underlying blood vessels.
REFERENCES:
patent: 4029084 (1977-06-01), Soldner
patent: 4309989 (1982-01-01), Fahim
patent: 4372296 (1983-02-01), Fahim
patent: 4657543 (1987-04-01), Langer et al.
patent: 4767402 (1988-08-01), Kost et al.
patent: 4787888 (1988-11-01), Fox
patent: 4821740 (1989-04-01), Tachibana et al.
patent: 4948587 (1990-08-01), Kost et al.
patent: 4953565 (1990-09-01), Tachibana et al.
patent: 5007438 (1991-04-01), Tachnibana et al.
patent: 5016615 (1991-05-01), Driller et al.
patent: 5019034 (1991-05-01), Weaver et al.
patent: 5053001 (1991-10-01), Reller et al.
patent: 5080646 (1992-01-01), Theeuwes et al.
patent: 5084008 (1992-01-01), Phipps
patent: 5115805 (1992-05-01), Bommannan et al.
patent: 5135478 (1992-08-01), Sibalis
patent: 5171215 (1992-12-01), Flanagan
patent: 5231975 (1993-08-01), Bommannan et al.
patent: 5267985 (1993-12-01), Shimada
Donald M. Skauen and Gaylen M. Zentner, "Phonophoresis," International Journal of Pharmaceutics, 20 (1984), pp. 235-245.
Katsuro Tachibana, "Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure," Pharmaceutical Research, vol. 19, No. 7, 1992, pp. 109-111.
D. Bommannan, Hirohisa Okuyama, Paul Stauffer, and Richard H. Guy, "Sonophoresis. I. The Use of High-Frequency Ultrasound to Enhance Transdermal Drug Delivery," Pharmaceutical Research, vol. 9, No. 4, 1992, pp. 559-564.
D. Bommannan, Gopinathan K. Menon, Hirohisa Okuyama, Peter M. Elias, and Richard H. Guy, "Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery," Pharmaceutical Research, vol. 9, No. 8, 1992, pp. 1043-1047,
J. C. McElnay, T. A. Kennedy, and R. Harland, "The influence of ultrasound on the percutaneous absorption of fluocinolone acetonide," International Journal of Pharmaceutics, 40 (1987), pp. 105-110.
Motoaki Shichiri, Yoshimitsu Yamasaki, Ryuzo Kawamori, Nobuyoshi Hakui, and Hiroshi Abe, "Wearable Artificial Endocrine Pancreas with Needle-type Glucose Sensor," The Lancet, Nov. 20, 1982, pp. 1129-1131.
Deborah Erickson, "Skinside Out," Scietific American, Nov. 1991, pp. 129-130.
Joseph Kost, "Ultrasound induced delivery of peptides," Journal of Controlled Release, 24 (1993), pp. 247-255.
Cohen Lee S.
Endodermic Medical Technologies Company
Gilbert Samuel
LandOfFree
Ultrasonic transdermal drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ultrasonic transdermal drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasonic transdermal drug delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-983572